Mumbai, July 2 -- Aurobindo Pharma has completed the transfer of the Company's domestic branded generic pharmaceutical formulations products business, as a going concern to Auropharm with effect from 01 July 2026.

Published by HT Digital Content Services with permission from Capital Market....